Prescription drug prices in the United States continue to rise, creating significant burdens for patients across the nation. Please join us for a discussion about reforming the generic drug sector in ways that can improve drug safety, spur economic growth, and reduce our reliance on overseas suppliers. RSVP is required.
Jon Clark, Founder, J. Edward Consulting; Former OPS Associate Director for Regulatory Policy at CDER, FDA; Former VP of Industry and Standards, U.S. Pharmacopeia
Ajaz Hussain, Ph.D., President of NIPTE; Former Deputy Director for Office of Pharmaceutical Science at CDER, FDA; Former VP Global Head Biopharmaceutical Development, Sandoz
Vadim Gurvich, Ph.D. MBA, Research Associate Professor, University of Minnesota; Executive Director of NIPTE
Kenneth Morris, Ph.D., Director of the Lachman Institute for Pharmaceutical Analysis, Long Island University
Rick Nader, Ph.D., Chief Research and International Officer, Long Island University
Please RSVP here.
**Breakfast and coffee will be served. This is a public and widely-attended event.**